Last reviewed · How we verify

NCT04164017

Impact of Suction in the EUS-guided Fine Needle Biopsy of Solid Pancreatic Lesions

Status unknown NA Last updated 15 November 2019
What this trial tests

NA trial testing EUS-guided FNB with Syringe Suction in Biopsy, Fine-Needle in 100 participants. Status unknown.

Timeline
1 June 2019
Primary endpoint
1 April 2020
1 April 2020

Quick facts

Lead sponsorCentro Hospitalar De São João, E.P.E.
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposediagnostic
Enrollment100
Start date1 June 2019
Primary completion1 April 2020
Estimated completion1 April 2020
Sites1 location across Portugal

Drugs / interventions tested

Conditions studied

Sponsor

Centro Hospitalar De São João, E.P.E.

Who can join

18 and older, any sex, with Biopsy, Fine-Needle or Endosonography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Tissue acquisition by Endoscopic Ultrasound (EUS) has become a modality of diagnosis and clinical orientation for several diseases. Although tissue acquisition traditionally involves the cytological diagnosis (using fine-needle aspiration/FNA), the importance of obtaining a core for histological examination (by fine-needle biopsy/FNB) has recently been recognized. Currently, there is no clear establishment of the usefulness of syringe suction for the diagnostic accuracy of solid pancreatic lesions when FNB is used. Because of that, the investigators aimed to compare sensitivity, sample adequacy, and diagnostic yield of solid pancreatic lesions EUS-guided sampling using with and without syringe suction. The study will be conducted on a consecutive sample of patients proposed to perform EUS for solid pancreatic lesions characterization, in which the clinical and imaging findings justify the need for an FNB. For each case, FNB will be performed using two punctures: one with 20mL syringe suction, and another without suction. The order in which they will be performed will be known only by the performing physician and the nursing team at the time that FNB is proposed. This information will be concealed from the pathologist responsible for sample analysis. Clinical care during and after the procedure will follow the existing guidelines. Participants will undergo a single clinical evaluation (at the time of endoscopy and recovery) without the need for follow-up visits.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Centro Hospitalar De São João, E.P.E. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04164017.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing